Table 3.
Antibiotic |
E. anophelis (n=12) |
E. meningoseptica (n=2) |
‘ E. bruuniana ’ (n=5) |
E. miricola (n=2) |
‘ E. ursingii ’ (n=1) |
---|---|---|---|---|---|
Amikacin |
100 |
100 |
100 |
100 |
100 |
Ceftazidime |
100 |
100 |
100 |
100 |
100 |
Ciprofloxacin |
41.7 |
50 |
40 |
50 |
0 |
Gentamicin |
100 |
100 |
100 |
100 |
0 |
Levofloxacin |
8.3 |
50 |
0 |
50 |
0 |
Meropenem |
100 |
100 |
100 |
100 |
100 |
Piperacillin/tazobactam† |
8.3 |
0 |
0 |
0 |
100 |
Tetracycline |
100 |
100 |
100 |
100 |
100 |
Tobramycin |
100 |
100 |
100 |
100 |
100 |
Trimethoprim/sulfamethoxazole‡ |
0 |
0 |
0 |
0 |
0 |
*The interpretive criteria applied were those of CLSI for non- Enterobacteriaceae (CLSI M100-S25) [25].
†The concentration of tazobactam was 4 µg ml−1 constant.
‡The ratio of trimethoprim to sulfamethoxazole was 1 to 19.